Federal court dismisses injunction against Sirtex Medical's A$30M share buyback
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Commercial Banking Newsletter June Edition - 2022
Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push
Sirtex Medical Ltd. said the Federal Court of Australia dismissed an injunction application which had delayed the company's A$30 million on-market share buyback.
The company said it plans to proceed with the buyback June 7.
As of May 26, US$1 was equivalent to A$1.34.